Market growth Market growth is largely driven by the growing prevalence of targeted therapies, the rising incidence of anaphylaxis, rising preference for self-administration of drugs, usability advantages, the increasing number of regulatory approvals, the availability of generic versions of autoinjectors, favorable reimbursements and government support, and technological advancements. The patent expiry of biologics is also expected to provide growth opportunities for players in the market. [180 Pages … Continue reading Autoinjectors Market worth USD 104.9 billion : Indicates Impressive Growth Rate In Medical Devices Industry